These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7812417)

  • 41. Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes.
    Lyngdorf LG; Gregersen S; Daugherty A; Falk E
    Cardiovasc Res; 2003 Oct; 59(4):854-62. PubMed ID: 14553825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity-induced diabetes in mouse strains treated with gold thioglucose: a novel animal model for studying β-cell dysfunction.
    Karasawa H; Takaishi K; Kumagae Y
    Obesity (Silver Spring); 2011 Mar; 19(3):514-21. PubMed ID: 20706204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal study on the establishment of insulin resistance in hypothalamic obese mice.
    Le Marchand Y; Freychet P; Jeanrenaud B
    Endocrinology; 1978 Jan; 102(1):74-85. PubMed ID: 369821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased hepatic glycogen synthetase and decreased phosphorylase in trained rats.
    Galbo H; Saugmann P; Richter EA
    Acta Physiol Scand; 1979 Nov; 107(3):269-72. PubMed ID: 120110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of glucopyranosylidene-spiro-thiohydantoin on glycogen metabolism in liver tissues of streptozotocin-induced and obese diabetic rats.
    Docsa T; Czifrák K; Hüse C; Somsák L; Gergely P
    Mol Med Rep; 2011; 4(3):477-81. PubMed ID: 21468595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of oxytetracycline treatment on enzymes of hepatic glycogen metabolism in genetically diabetic (db/db) mice.
    Benzo CA
    Biochem Med Metab Biol; 1987 Feb; 37(1):42-50. PubMed ID: 3105560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.
    Müller C; Assimacopoulos-Jeannet F; Mosimann F; Schneiter P; Riou JP; Pachiaudi C; Felber JP; Jéquier E; Jeanrenaud B; Tappy L
    Diabetologia; 1997 Apr; 40(4):463-8. PubMed ID: 9112024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The activity of the pyruvate dehydrogenase complex in heart and liver from mice during the development of obesity and insulin resistance.
    Caterson ID; Astbury LD; Williams PF; Vanner MA; Cooney GJ; Turtle JR
    Biochem J; 1987 Apr; 243(2):549-53. PubMed ID: 3115255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lithium's effects on rat liver glucose metabolism in vivo.
    Rodriguez-Gil JE; Fernández-Novell JM; Barberá A; Guinovart JJ
    Arch Biochem Biophys; 2000 Mar; 375(2):377-84. PubMed ID: 10700396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Change in sensitivity to insulin hypoglycemic convulsions after gold thioglucose treatment: time course of development.
    Luby JL; Holliday JF; Fish KW; Marrazzi MA
    J Pharmacol Exp Ther; 1981 Oct; 219(1):258-67. PubMed ID: 6793712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Injection with gold thioglucose impairs sensitivity to glucose: evidence that glucose-responsive neurons are important for long-term regulation of body weight.
    Bergen HT; Monkman N; Mobbs CV
    Brain Res; 1996 Sep; 734(1-2):332-6. PubMed ID: 8896843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice.
    Ventre J; Doebber T; Wu M; MacNaul K; Stevens K; Pasparakis M; Kollias G; Moller DE
    Diabetes; 1997 Sep; 46(9):1526-31. PubMed ID: 9287059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and gold-thioglucose-induced obesity in mice.
    Saito M; Bray GA
    Endocrinology; 1983 Dec; 113(6):2181-5. PubMed ID: 6416815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivation of pyruvate dehydrogenase complex in heart muscle mitochondria of gold-thioglucose-induced obese mice is not due to a stable increase in activity of pyruvate dehydrogenase kinase.
    Caterson ID; Kerbey AL; Cooney GJ; Frankland R; Denyer GS; Nicks J; Williams PF
    Biochem J; 1988 Jul; 253(1):291-4. PubMed ID: 3138985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of gold thioglucose treatment on enzymes of glycogen metabolism in liver and skeletal muscle in mice.
    Benzo CA; Stearns SB
    Biochem Med; 1981 Dec; 26(3):395-402. PubMed ID: 6800361
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of chronic metformin treatment of hepatic and muscle glycogen metabolism in KK mice.
    Reddi AS; Jyothirmayi GN
    Biochem Med Metab Biol; 1992 Apr; 47(2):124-32. PubMed ID: 1515171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The activity of the pyruvate dehydrogenase complex in heart muscle in the previously obese mouse model.
    Steinbeck K; Caterson ID; Turtle JR
    Biosci Rep; 1986 Dec; 6(12):1071-5. PubMed ID: 3107627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin response in individual tissues of control and gold thioglucose-obese mice in vivo with [1-14C]2-deoxyglucose.
    Cooney GJ; Astbury LD; Williams PF; Caterson ID
    Diabetes; 1987 Feb; 36(2):152-8. PubMed ID: 3100366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term oral nicotine administration reduces insulin resistance in obese rats.
    Liu RH; Mizuta M; Matsukura S
    Eur J Pharmacol; 2003 Jan; 458(1-2):227-34. PubMed ID: 12498930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetic properties of glycogen synthase and phosphorylase and structural aspects of glycogen in the db/db mouse liver.
    Roesler WJ; Khandelwal RL
    Diabetes; 1986 Feb; 35(2):210-6. PubMed ID: 3080350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.